Connor, Clark & Lunn Investment Management Ltd. Chroma Dex Corp. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Chroma Dex Corp. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 506,186 shares of CDXC stock, worth $3.43 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
506,186
Previous 175,172
188.97%
Holding current value
$3.43 Million
Previous $639,000
320.5%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CDXC
# of Institutions
129Shares Held
21.9MCall Options Held
203KPut Options Held
23.9K-
Vanguard Group Inc Valley Forge, PA3.39MShares$22.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$21.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.59MShares$17.5 Million5.52% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$8.78 Million0.14% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$7.82 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $463M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...